Before (n=366) | After (n=247) | P value | |
LVEF, mean±SD (95% CI), % | 52.7±11.1 (51.6 to 53.9) | 53.2±9.85 (52.0 to 54.4) | 0.66 |
sPAP, mean±SD (95% CI), mm Hg | 47.2±15.8 (45.4 to 49.1) | 43.3±15.1 (41.2 to 45.4) | 0.0079 |
Right midventricular diameter, mean±SD (95% CI), mm | 29.5±6.60 (28.8 to 30.2) | 29.9±6.00 (29.1 to 30.8) | 0.088 |
TAPSE, mean±SD (95% CI), mm | 19.6±5.02 (19.1 to 20.2) | 19.8±5.14 (19.2 to 20.5) | 0.72 |
LA area, mean±SD (95% CI), cm2 | 26.3±8.29 (25.4 to 27.2) | 26.3±7.86 (25.3 to 27.3) | 0.12 |
RA area, mean±SD (95% CI), cm2 | 20.5±7.47 (19.7 to 21.4) | 20.9±7.94 (19.9 to 22.0) | 0.86 |
MR≥III/IV°, n (%) | 34 (9.29%) | 9 (3.64%) | 0.0015 |
TR≥III/IV°, n (%) | 33 (9.02%) | 25 (10.1%) | 0.53 |
Comparison was calculated by paired samples Wilcoxon test.
LA area, left atrial area; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; RA area, right atrial area; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; TAVR, transcatheter aortic valve replacement; TR, tricuspid regurgitation.